Histamine liberation and membrane fluidisation of mast cells exposed to the beta-adrenoceptor blocking drug propranolol
- 1 May 1988
- journal article
- histamine release
- Published by Springer Nature in Inflammation Research
- Vol. 23 (3-4) , 143-145
- https://doi.org/10.1007/bf02142523
Abstract
Propranolol liberates histamine from isolated mast cells and decreases the uptake of extracellular histamine in a dose-dependent way. Histamine liberation due to propranolol is accompanied by calcium displacement from intracellular storage sites. The significant increase in membrane fluidity due to propranolol is temperature dependent. The perturbation of membranes is most probably the explanation of propranolol's interaction with isolated rat mast cells which results in altered histamine transportation.Keywords
This publication has 9 references indexed in Scilit:
- On the relationship between incorporation of32P into phospholipids and binding of beta-adrenoceptor blocking drugs to isolated mast cellsInflammation Research, 1988
- Amine transport in isolated rat mast cells treated with betaadrenoceptor blocking drugsInflammation Research, 1986
- The interaction of β-adrenoceptor blocking drugs with platelet aggregation, calcium displacement and fluidization of the membraneBiochimica et Biophysica Acta (BBA) - Biomembranes, 1985
- On the interaction of beta-adrenoceptor-blocking drugs with isolated mast cellsInflammation Research, 1985
- COMPARISONS OF THE INTERACTION OF PROPRANOLOL AND TIMOLOL WITH MODEL AND BIOLOGICAL MEMBRANE SYSTEMS1983
- Evidence for intracellular histamine liberation in isolated rat mast cellsInflammation Research, 1982
- Propranolol-induced bronchoconstriction: A non-specific side-effect of β-adrenergic blocking therapyEuropean Journal of Pharmacology, 1981
- The effect of beta-adrenergic blocking drugs and inhibitors of phosphodiesterase on histamine release from isolated mast cellsInflammation Research, 1977
- Effect of propranolol on ventilatory functionThe American Journal of Cardiology, 1966